ABBOTT LABORATORIES - Common Stock (ABT)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: ABT on NYSE
Shares outstanding: 1,740,239,592
Price per share: $125.29
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 1,353,060,060
Holdings value: $181,143,827,869
% of all portfolios: 0.14%
Share change: -20,150,814
Value change: -$2,756,911,465
Average buys %: +0.01%
Average sells %: -0.01%
Number of holders: 3,129
Price from insider filings: $123.28

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of ABBOTT LABORATORIES - Common Stock (ABT) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10%		$22,211,548,033		174,894,079		The Vanguard Group	28 Nov 2025

As of 30 Sep 2025, ABBOTT LABORATORIES - Common Stock (ABT) has 3,129 institutional shareholders filing 13F forms. They hold 1,353,060,060 shares of 1,740,239,592 outstanding shares (78%) .

Top 25 institutional shareholders own 49% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	10%	173,154,308	+0.2%	0.35%	$23,192,288,014
BlackRock, Inc.	8.1%	141,559,956	+0.19%	0.33%	$18,960,540,594
STATE STREET CORP	4.5%	78,225,991	-0.16%	0.36%	$10,477,589,235
Capital International Investors	3.5%	61,614,739	+2.5%	1.3%	$8,251,973,846
Capital Research Global Investors	2.2%	38,768,839	-7.2%	0.97%	$5,192,680,251
MORGAN STANLEY	2.2%	38,634,796	+9.7%	0.31%	$5,174,745,037
GEODE CAPITAL MANAGEMENT, LLC	2.2%	38,541,894	+0.65%	0.33%	$5,138,229,944
JPMORGAN CHASE & CO	1.7%	29,383,217	-25%	0.25%	$3,935,602,588
WELLINGTON MANAGEMENT GROUP LLP	1.3%	23,246,144	-7.2%	0.55%	$3,113,588,527
BANK OF AMERICA CORP /DE/	1.2%	20,805,826	-4.1%	0.21%	$2,786,732,240
NORTHERN TRUST CORP	1.2%	20,442,820	-2.8%	0.35%	$2,738,111,311
T. Rowe Price Investment Management, Inc.	1%	17,769,095	+112%	1.5%	$2,379,993,000
WELLS FARGO & COMPANY/MN	0.96%	16,707,340	-2.8%	0.46%	$2,237,781,227
GOLDMAN SACHS GROUP INC	0.93%	16,128,211	+6.1%	0.31%	$2,160,212,460
PRICE T ROWE ASSOCIATES INC /MD/	0.91%	15,800,759	+53%	0.23%	$2,116,355,000
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	0.87%	15,096,907	+5.8%	0.63%	$2,022,079,724
Invesco Ltd.	0.8%	13,951,907	+51%	0.29%	$1,868,718,439
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	0.78%	13,587,118	0%	1.5%	$1,819,858,585
AMERIPRISE FINANCIAL INC	0.78%	13,500,829	+3.8%	0.41%	$1,804,050,308
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.75%	13,137,337	-0.3%	0.28%	$1,759,615,804
Legal & General Group Plc	0.74%	12,900,318	+7.2%	0.39%	$1,727,868,591
Bank of New York Mellon Corp	0.73%	12,678,513	-0.47%	0.3%	$1,698,160,020
Fisher Asset Management, LLC	0.69%	12,032,884	+1.4%	0.58%	$1,611,684,674
Nuveen, LLC	0.67%	11,654,561	-4.6%	0.41%	$1,561,011,931
FMR LLC	0.67%	11,592,594	-15%	0.08%	$1,552,712,104

Institutional Holders of ABBOTT LABORATORIES - Common Stock (ABT) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	8,312,318	$1,050,268,396	+$192,443,307			$125.29	166
2025 Q3	1,353,060,060	$181,143,827,869	-$2,756,911,465	$1,094,806,792	$1,324,182,319	$133.94	3,129
2025 Q2	1,373,457,328	$186,724,601,473	+$3,689,370,737	$984,050,549	$1,190,798,948	$136.01	3,151
2025 Q1	1,346,771,278	$178,533,526,723	+$454,572,264	$1,066,676,118	$1,230,814,569	$132.65	3,118
2024 Q4	1,344,469,848	$152,125,714,058	+$6,806,996,831	$892,314,424	$1,137,484,789	$113.11	3,001
2024 Q3	1,279,077,837	$145,822,144,868	-$4,171,717,184	$912,604,110	$990,236,464	$114.01	2,856
2024 Q2	1,317,797,773	$136,928,637,847	+$3,845,563,178	$737,676,751	$891,749,395	$103.91	2,818
2024 Q1	1,275,996,179	$144,896,947,002	-$2,869,288,367	$983,431,929	$955,784,962	$113.66	2,874
2023 Q4	9,723,307	$1,069,519,684	-$117,749,537			$110.07	52
2023 Q3	1,272,039,180	$123,240,982,318	+$508,805,486	$655,597,972	$884,816,331	$96.85	2,623
2023 Q2	1,276,941,179	$139,035,362,507	-$2,115,702,884	$705,092,338	$846,536,768	$109.02	2,674
2023 Q1	1,281,772,665	$129,811,257,900	+$625,584,859	$700,549,515	$762,550,181	$101.26	2,647
2022 Q4	1,288,009,982	$141,473,478,501	+$395,189,409	$906,226,860	$1,123,224,055	$109.79	2,704
2022 Q3	1,287,287,219	$124,654,444,415	+$273,015,486	$763,132,925	$869,978,614	$96.76	2,563
2022 Q2	1,274,552,002	$138,401,376,743	+$1,371,045,155	$470,095,271	$669,456,402	$108.65	2,641
2022 Q1	1,283,904,079	$152,046,517,519	-$1,514,622,821	$732,919,216	$880,684,591	$118.36	2,708
2021 Q4	1,278,700,730	$179,840,586,022	-$1,005,861,355	$1,318,526,302	$1,285,268,074	$140.74	2,767
2021 Q3	1,298,949,461	$153,469,632,147	-$416,591,935	$997,027,332	$894,331,519	$118.13	2,493
2021 Q2	1,301,998,167	$150,936,354,536	-$1,527,689,195	$883,559,499	$762,150,884	$115.93	2,467
2021 Q1	1,313,268,418	$157,350,266,908	+$1,341,319,062	$747,404,089	$766,871,704	$119.84	2,485
2020 Q4	1,272,007,028	$139,242,587,576	+$205,431,850	$716,867,742	$785,726,000	$109.49	2,441
2020 Q3	1,304,473,145	$141,854,955,251	-$20,586,892	$833,938,272	$801,361,904	$108.83	2,272
2020 Q2	1,302,804,339	$119,161,727,966	-$1,230,576,542	$554,379,737	$539,597,136	$91.43	2,217
2020 Q1	1,275,734,075	$100,717,377,744	+$339,369,393	$431,776,128	$506,027,000	$78.91	2,094
2019 Q4	1,295,353,379	$112,502,136,597	+$655,263,759	$620,531,014	$643,949,000	$86.86	2,163
2019 Q3	1,320,175,032	$110,423,661,801	+$66,665,828	$510,277,052	$540,885,000	$83.67	2,007
2019 Q2	1,311,084,404	$110,248,378,570	+$3,306,448,414	$348,142,069	$575,487,000	$84.10	1,987
2019 Q1	1,288,582,797	$102,982,841,061	-$654,320,809	$305,280,101	$523,329,014	$79.94	1,978
2018 Q4	1,319,971,174	$95,442,629,714	+$1,904,105,396	$350,534,084	$654,067,161	$72.33	1,950
2018 Q3	1,273,495,778	$93,395,744,877	+$2,942,457,247	$452,890,044	$665,974,449	$73.36	1,843
2018 Q2	1,254,107,344	$76,479,180,365	+$96,503,078	$173,973,081	$269,275,125	$60.99	1,789
2018 Q1	1,272,613,096	$76,238,682,220	+$362,535,145	$192,811,257	$265,087,740	$59.92	1,784
2017 Q4	1,266,677,651	$72,289,572,970	-$444,138,612	$249,035,893	$270,341,615	$57.07	1,733
2017 Q3	1,272,479,366	$67,908,133,535	+$610,911,267	$256,796,000	$338,540,065	$53.36	1,582
2017 Q2	1,257,684,377	$61,133,853,530	+$727,440,780	$267,275,006	$290,360,832	$48.61	1,559
2017 Q1	1,249,027,281	$55,466,422,811	+$10,499,695,148	$227,753,066	$255,723,400	$44.41	1,579
2016 Q4	1,102,603,374	$42,371,462,434	+$382,774,420	$268,142,000	$238,795,000	$38.41	1,507
2016 Q3	1,089,657,769	$46,055,892,051	+$1,051,988,012	$258,463,000	$449,696,000	$42.29	1,476
2016 Q2	1,063,889,466	$41,836,282,966	+$1,689,331,773	$186,027,000	$203,672,000	$39.31	1,461
2016 Q1	1,021,042,874	$42,703,883,836	-$166,959,200	$122,647,000	$144,387,000	$41.83	1,453
2015 Q4	1,027,426,304	$46,139,104,642	-$502,290,049	$229,118,000	$242,817,000	$44.91	1,494
2015 Q3	1,034,599,722	$41,616,771,081	+$280,798,539	$212,793,000	$291,535,000	$40.22	1,448
2015 Q2	1,010,913,665	$49,621,026,056	+$345,396,541	$639,114,000	$480,522,000	$49.08	1,473
2015 Q1	1,027,156,427	$47,581,322,011	-$627,926,143	$169,836,000	$218,234,000	$46.33	1,458
2014 Q4	1,042,107,179	$46,915,020,736	+$358,419,072	$257,966,000	$258,342,000	$45.02	1,463
2014 Q3	1,026,674,870	$42,700,060,995	+$356,799,354	$195,589,000	$194,995,000	$41.59	1,382
2014 Q2	1,019,202,783	$41,682,846,883	+$108,450,512	$143,474,000	$284,624,000	$40.90	1,372
2014 Q1	1,018,101,186	$39,199,601,132	-$1,308,802,252	$151,523,000	$156,461,000	$38.51	1,363